Induction of apoptosis in MCF-7: WS8 breast cancer cells by β-lapachone Journal Article


Authors: Wuerzberger, S. M.; Pink, J. J.; Planchon, S. M.; Byers, K. L.; Bornmann, W. G.; Boothman, D. A.
Article Title: Induction of apoptosis in MCF-7: WS8 breast cancer cells by β-lapachone
Abstract: β-Lapachone (β-lap) affects a number of enzymes in vitro, including type I topoisomerase (Topo I); however, its exact intracellular target(s) and mechanism of cell killing remain unknown. We compared the cytotoxic responses of MCF-7:WS8 (MCF-7) human breast cancer cells after 4-h pulses of β-lap or camptothecin (CPT), a known Topo I poison. A direct correlation between loss of survival and apoptosis was seen after β-lap treatment (LD50 = 2.5 μM). A concentration-dependent, transient sub-2 N preapoptotic cell population was observed at 4-8 h. Estrogen deprivation-induced synchronization and bromodeoxyuridine-labeling studies revealed an apoptotic exit point near the G1-S border. Apoptosis activated by β-lap was closely correlated with cleavage of lamin B but not with increases in p53/p21 or decreases in bcl-2. Loss of hyperphosphorylated forms of the retinoblastoma protein was observed within 5 h, but cyclins A, B1, and E levels were unaltered for up to 72 h after 5 μM β-lap. Topo I and Topo IIα levels decreased at >24 h. Logarithmic-phase MCF-7 cells were not affected by ≤1 μM β-lap. In contrast, dramatic and irreversible G2-M arrest with no apoptosis was observed in MCF-7 cells treated with 1 μM CPT, monitored for 6-10 days posttreatment. MCF-7 cells treated with supralethal doses of CPT (5 μM) resulted in only ~20% apoptosis. No correlation between apoptosis and loss of survival was observed. MCF-7 cells exposed to >5 μM CPT arrested at key cell cycle checkpoints (i.e., G1, S, and G2-M), with little or no movement for 6 days. Ten-fold increases in p53/p21 and 2-5-fold decreases in bcl-2, Topo I, Topo IIα, and cyclins A and B1, with no change in cyclin E, were observed. Temporal decreases in bcl-2 and cleavage of lamin B corresponded to the minimal apoptotic response observed. β-Lap activated apoptosis without inducing p53/p21 or cell cycle arrest responses and killed MCF-7 cells solely by apoptosis. In contrast, concentration-dependent increases in nuclear p53/p21 and various cell cycle checkpoint arrests were seen in MCF-7 cells after CPT. Despite dramatic p53/p21 protein induction responses, CPT-treated MCF-7 cells showed low levels of apoptosis, possibly due to protective cell cycle checkpoints or the lack of specific CPT-activated apoptotic pathways in MCF-7 cells.
Keywords: protein expression; unclassified drug; human cell; flow cytometry; antineoplastic agent; cell cycle proteins; cell survival; cell cycle; apoptosis; breast cancer; antineoplastic agents, phytogenic; camptothecin; antineoplastic activity; cancer cell culture; dose-response relationship, drug; tumor cells, cultured; breast neoplasms; tumor suppressor protein p53; cyclin-dependent kinase inhibitor p21; cyclins; cell strain mcf 7; proto-oncogene proteins c-bcl-2; dna topoisomerase; dna topoisomerases, type i; mitosis inhibition; beta lapachone; lethal dose 50; reverse transcriptase inhibitors; humans; human; female; priority journal; article; naphthoquinones
Journal Title: Cancer Research
Volume: 58
Issue: 9
ISSN: 0008-5472
Publisher: American Association for Cancer Research  
Date Published: 1998-05-01
Start Page: 1876
End Page: 1885
Language: English
PUBMED: 9581828
PROVIDER: scopus
DOI/URL:
Notes: Article -- Export Date: 12 December 2016 -- Source: Scopus
Citation Impact
MSK Authors
  1. William Bornmann
    112 Bornmann